Process Solutions: Portfolio Announcement
Merck Acquires Data Management and Analysis Platform for Biopharma Real-Time
Process Monitoring and Reporting
"Most of these core process functions create
and consume process data in similar way
with similar
underlying
metadata/context.
ProcessPad platform help manage and serve
contextual process information through
the lfe
cycle of QbD-OAT-CPV"
- Web-based platform provides easy on-demand access, across functions and with
suppliers, to data for aggregation, analysis, visualization and management
- Advances company’s BioContinuum™ Platform to deliver contiguous manufacturing
Merck has acquired all ownership rights to the ProcessPad™ platform from Simplyfeye Softwares Private Limited. The
agreement includes the transfer of all copyrights and relevant intellectual property related to this software
platform.
August 21, 2019
The ProcessPad™ platform is a data management and analytics solution developed specifically for the pharmaceutical
and
biopharmaceutical industry. The platform:
- Aggregates data from a variety of external data sources for various batches,
parameters
and unit operations, efficiently capturing all development, scale-up, commercial and process data on one single
platform
- Advances company’s BioContinuum™ Platform to deliver contiguous manufacturing
- Visualizes the data by generating a variety of report, charts, and tables for annual
product reviews, root cause investigations and corrective and preventive action (CAPA) implementation, etc.
- Manages data simply through easy browser-based access to all process data from a variety of diverse stakeholders
The acquisition of the platform is another building block for Merck’s BioContinuum™
Platform, a confluent offering of intensified, advanced processing and digital technologies and services
that
allow a customer to go beyond continuous processing. The BioContinuum™ Platform will deliver contiguous
manufacturing
for Biopharma 4.0, the industry-specific global vision and initiative based on Industry 4.0.
